Table VI.
BALB.B
|
CXB-2
|
|||
---|---|---|---|---|
Vβ | Length | Tissue | Length | Tissue |
1 | ||||
2 | 167 | S, I, L | 167 | S, I, L |
3 | ||||
4 | ||||
5 | 176 | S, I, L | 176 | I, L |
6 | 143 | I, L | ||
7 | 171; 176 | I, L; S, L | 180 | S, I, L |
8.1 | ||||
8.2 | ||||
8.3 | 173 | S, I, L | 157 | S, I |
9 | 153; 156 | S, I, L; S, I | 153; 142 | S, I, L; I, L |
10 | 130,132 | S, I, L | 130 | S, I, L |
11 | 158 | S, I, L | 158 | S, L |
12 | ||||
13 | 163 | S, L | 160 | S, I, L |
14 | ||||
15 | ||||
16 | ||||
18 | 219 | S, I | ||
20 | 197 | S, I, L |
CDR3-size lengths significantly skewed compared to that of normal B6 control for the respective Vβ family. S, Spleen; I, Intestine; and L, Liver.